New Year, Not So New Anti-Kickback Statute Enforcement Trends at the DOJ

Judging by 2023’s criminal investigations and civil actions under the federal Anti-Kickback Statute and the False Claims Act, medical businesses should be on their guard in 2024. In this guest article, Lowenstein Sandler lawyers Scott B. McBride and Jessica M. Terry survey the DOJ’s recent pursuit of such violations in the healthcare industry and draw conclusions about what to expect in 2024. See “Implications of the Updates to the Pharmaceutical Research and Manufacturers of America Code” (Sep. 29, 2021).

To read the full article

Continue reading your article with an ACR subscription.